Finance

Beta
Lists
XNCR:NASDAQ
Xencor Inc
$14.01
+10.84%
(+1.37) 1D
$13.70
-2.21% (-0.31)
Pre-market
Closed: Jun 22, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for XNCR...
Open
$12.89
High
$14.21
Low
$12.89
Mkt. cap
1.04B
Avg. vol.
765.51K
Volume
868.00
52-wk high
$18.69
52-wk low
$6.92
EPS
-$2.30
Beta
0.92
Shares outstanding
74.14M
No. of employees
260
Open
$12.89
High
$14.21
Low
$12.89
Mkt. cap
1.04B
Avg. vol.
765.51K
Volume
868.00
52-wk high
$18.69
52-wk low
$6.92
EPS
-$2.30
Beta
0.92
Shares outstanding
74.14M
No. of employees
260
About Xencor Inc
CEO-
Employees260
Founded1997
HeadquartersPasadena, California, United States
SectorBiotechnology
Websitexencor.com
Analyst Ratings
Based on 11 analysts giving stock ratings to XNCR in the past 3 months
Strong Buy
Buy
9
Hold
2
Sell
0
12 month forecast
Based on 11 Wall Street analysts offering 12 month price targets for XNCR in the last 3 months.
Highest
Current $14.01
$38.00 (+171.23%)
Average
$24.30 (+73.45%)
Lowest
$13.00 (-7.21%)
Analyst
Recommendation
Action
Price Target
Projected
Date
Etzer Darout
Barclays
Buy
Maintained
$27.00
+92.7%
06/16/2026
Alec Stranahan
Bank of America Securities
Hold
Maintained
$17.00
+21.3%
05/13/2026
Tara Bancroft
TD Cowen
Buy
Maintained
-
-
05/11/2026
Brian Cheng
J.P. Morgan
Hold
Reiterated
$14.00
-0.1%
05/11/2026
Unknown Analyst
Wedbush
Buy
Maintained
$26.00
+85.6%
05/07/2026
Edward Tenthoff
Piper Sandler
Buy
Reiterated
$33.00
+135.5%
05/08/2026
John Newman
Canaccord Genuity
Buy
Maintained
$38.00
+171.2%
05/06/2026
Unknown Analyst
Wells Fargo
Buy
Maintained
$27.00
+92.7%
05/07/2026
Gregory Renza
Truist Financial
Buy
Reiterated
$29.00
+107%
05/07/2026
Leonid Timashev
RBC Capital
Buy
Maintained
$19.00
+35.6%
05/05/2026
Matt Phipps
William Blair
Buy
Reiterated
$13.00
-7.2%
05/06/2026
Steven Seedhouse
Cantor Fitzgerald
Buy
Reiterated
$43.00
+206.9%
02/25/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
43.61M
21.00M
28.24M
4.52M
Cost of goods sold
61.66M
54.37M
64.82M
64.67M
Cost of revenue
61.66M
54.37M
64.82M
64.67M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
15.12M
14.15M
17.04M
17.71M
Operating expense
15.12M
14.15M
17.04M
17.71M
Total operating expenses
76.78M
68.52M
81.86M
82.38M
Operating income
-33.17M
-47.52M
-53.63M
-77.86M
Other non operating income
-17.00K
-17.00K
-8.00K
396.00K
EBT including unusual items
-31.08M
-6.03M
-4.27M
-128.64M
EBT excluding unusual items
-34.18M
-48.66M
-54.79M
-76.71M
Income tax expense
-250.00K
-
2.39M
280.00K
Effective tax rate
0.80%
-
-55.95%
-0.22%
Other operating expenses
-
-
-
-
Net income
-30.82M
-6.03M
-6.65M
-128.92M
Net profit margin
-70.69%
-28.70%
-23.56%
-2,854.65%
Earnings per share
-0.41
-0.08
-0.09
-1.71
Interest and investment income
7.25M
6.54M
6.20M
5.46M
Interest expense
-8.24M
-7.66M
-7.35M
-4.70M
Net interest expenses
-995.00K
-1.13M
-1.15M
759.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-30.52M
-44.93M
-51.05M
-75.30M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer